Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066701380> ?p ?o ?g. }
- W2066701380 endingPage "695" @default.
- W2066701380 startingPage "688" @default.
- W2066701380 abstract "Background and Purpose Postischemic metabolic injury may be mediated by acidosis and tissue bicarbonate depletion, with consequent iron mobilization and oxygen radical formation during reperfusion. We have previously shown that reducing intracellular pH to below 5.7 and bicarbonate ion to below 1 to 2 mmol/L during hyperglycemic ischemia produces a profound secondary deterioration of brain ATP and cerebral blood flow during reperfusion. This study tested the hypothesis that pretreatment with free deferoxamine ameliorates metabolic decay and delayed hypoperfusion after global hyperglycemic ischemia. In addition, deferoxamine conjugated to a high-molecular-weight starch was administered to determine the importance of an intravascular site of action. Iron-loaded deferoxamine was used to determine whether the iron chelation properties of deferoxamine are important to postischemic viability as distinguished from the agent’s significant radical scavenging potential. Methods Cerebral ATP, phosphocreatine, and pH were measured by 31 P magnetic resonance spectroscopy in anesthetized dogs. Tissue bicarbonate concentration was calculated from the Henderson-Hasselbalch equation. Incomplete cerebral ischemia was produced by intracranial pressure elevation for 30 minutes with plasma glucose at 540±15 mg/dL. Free deferoxamine, saline vehicle, hydroxyethyl starch–conjugated deferoxamine, hydroxyethyl starch vehicle, and deferoxamine loaded with equimolar ferric chloride were administered intravenously in five groups of dogs. The dose of deferoxamine was 50 mg/kg before ischemia, 50 mg/kg at the onset of reperfusion, and 50 mg/kg over the 180-minute reperfusion period. Results Ischemic hemispheric blood flow (mean, 6 to 8 mL/min per 100 g), intracellular pH (5.7 to 6.0), and bicarbonate levels (1 to 2 mmol/L) were similar in all groups. During reperfusion, cerebral pH and bicarbonate recovered only in the free-deferoxamine group. Both ATP and phosphocreatine initially increased in all groups, but recovery was sustained only in the free-deferoxamine group. Secondary losses of energy phosphates and cerebral oxygen consumption were observed in all other groups, accompanied by progressive reduction of perfusion. Conclusions These data support the hypothesis that iron-catalyzed oxygen radical production plays an important role in acidosis-mediated mechanisms of ischemic brain injury. The results with free and iron-loaded deferoxamine suggest that iron scavenging is an important, but not necessarily the principal, component of this mechanism. The poor recovery seen with conjugated deferoxamine indicates that the beneficial action of deferoxamine is not localized within the intravascular compartment." @default.
- W2066701380 created "2016-06-24" @default.
- W2066701380 creator A5005438739 @default.
- W2066701380 creator A5006130007 @default.
- W2066701380 creator A5014756640 @default.
- W2066701380 creator A5060319184 @default.
- W2066701380 date "1995-04-01" @default.
- W2066701380 modified "2023-09-23" @default.
- W2066701380 title "Deferoxamine Reduces Early Metabolic Failure Associated With Severe Cerebral Ischemic Acidosis in Dogs" @default.
- W2066701380 cites W1498235500 @default.
- W2066701380 cites W1967301594 @default.
- W2066701380 cites W1977597523 @default.
- W2066701380 cites W1978860390 @default.
- W2066701380 cites W1979753452 @default.
- W2066701380 cites W1983479470 @default.
- W2066701380 cites W1989718339 @default.
- W2066701380 cites W1998827607 @default.
- W2066701380 cites W2004395689 @default.
- W2066701380 cites W2019048519 @default.
- W2066701380 cites W2023672783 @default.
- W2066701380 cites W2025879604 @default.
- W2066701380 cites W2026635177 @default.
- W2066701380 cites W2028744220 @default.
- W2066701380 cites W2040586856 @default.
- W2066701380 cites W2052594454 @default.
- W2066701380 cites W2060858729 @default.
- W2066701380 cites W2066349475 @default.
- W2066701380 cites W2080307106 @default.
- W2066701380 cites W2083321303 @default.
- W2066701380 cites W2087542860 @default.
- W2066701380 cites W2090879317 @default.
- W2066701380 cites W2090907291 @default.
- W2066701380 cites W2092101890 @default.
- W2066701380 cites W2094978651 @default.
- W2066701380 cites W2098877347 @default.
- W2066701380 cites W2124333911 @default.
- W2066701380 cites W213077994 @default.
- W2066701380 cites W2143007633 @default.
- W2066701380 cites W2205040467 @default.
- W2066701380 cites W2284280435 @default.
- W2066701380 cites W4243202494 @default.
- W2066701380 doi "https://doi.org/10.1161/01.str.26.4.688" @default.
- W2066701380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7709418" @default.
- W2066701380 hasPublicationYear "1995" @default.
- W2066701380 type Work @default.
- W2066701380 sameAs 2066701380 @default.
- W2066701380 citedByCount "69" @default.
- W2066701380 countsByYear W20667013802012 @default.
- W2066701380 countsByYear W20667013802013 @default.
- W2066701380 countsByYear W20667013802015 @default.
- W2066701380 countsByYear W20667013802016 @default.
- W2066701380 countsByYear W20667013802017 @default.
- W2066701380 countsByYear W20667013802021 @default.
- W2066701380 countsByYear W20667013802023 @default.
- W2066701380 crossrefType "journal-article" @default.
- W2066701380 hasAuthorship W2066701380A5005438739 @default.
- W2066701380 hasAuthorship W2066701380A5006130007 @default.
- W2066701380 hasAuthorship W2066701380A5014756640 @default.
- W2066701380 hasAuthorship W2066701380A5060319184 @default.
- W2066701380 hasConcept C126322002 @default.
- W2066701380 hasConcept C157767197 @default.
- W2066701380 hasConcept C2776672577 @default.
- W2066701380 hasConcept C2778553927 @default.
- W2066701380 hasConcept C2778626300 @default.
- W2066701380 hasConcept C2779246250 @default.
- W2066701380 hasConcept C2779412105 @default.
- W2066701380 hasConcept C2779493303 @default.
- W2066701380 hasConcept C2781112554 @default.
- W2066701380 hasConcept C2986317502 @default.
- W2066701380 hasConcept C42219234 @default.
- W2066701380 hasConcept C541997718 @default.
- W2066701380 hasConcept C71924100 @default.
- W2066701380 hasConcept C98274493 @default.
- W2066701380 hasConceptScore W2066701380C126322002 @default.
- W2066701380 hasConceptScore W2066701380C157767197 @default.
- W2066701380 hasConceptScore W2066701380C2776672577 @default.
- W2066701380 hasConceptScore W2066701380C2778553927 @default.
- W2066701380 hasConceptScore W2066701380C2778626300 @default.
- W2066701380 hasConceptScore W2066701380C2779246250 @default.
- W2066701380 hasConceptScore W2066701380C2779412105 @default.
- W2066701380 hasConceptScore W2066701380C2779493303 @default.
- W2066701380 hasConceptScore W2066701380C2781112554 @default.
- W2066701380 hasConceptScore W2066701380C2986317502 @default.
- W2066701380 hasConceptScore W2066701380C42219234 @default.
- W2066701380 hasConceptScore W2066701380C541997718 @default.
- W2066701380 hasConceptScore W2066701380C71924100 @default.
- W2066701380 hasConceptScore W2066701380C98274493 @default.
- W2066701380 hasIssue "4" @default.
- W2066701380 hasLocation W20667013801 @default.
- W2066701380 hasLocation W20667013802 @default.
- W2066701380 hasOpenAccess W2066701380 @default.
- W2066701380 hasPrimaryLocation W20667013801 @default.
- W2066701380 hasRelatedWork W183192062 @default.
- W2066701380 hasRelatedWork W1865831986 @default.
- W2066701380 hasRelatedWork W1989378067 @default.
- W2066701380 hasRelatedWork W201429034 @default.
- W2066701380 hasRelatedWork W2056840381 @default.
- W2066701380 hasRelatedWork W2066701380 @default.